Dr. Folefac Aminkeng Publishes in Nature Genetics
![](https://www.goldenhelix.com/blog/wp-content/uploads/2015/08/Folefac_Large.png)
Today I wanted to take a moment to recognize a long-time Golden Helix customer, Dr. Folefac Aminkeng of the Canadian Pharmacogenomics Network for Drug Safety and the University of British Columbia on his recent publication A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer, in Nature Genetics. Aminkeng and his colleagues performed a genome-wide association study in… Read more »